MENU
+Compare
MRK
Stock ticker: NYSE
AS OF
Dec 3 closing price
Price
$102.27
Change
+$1.24 (+1.23%)
Capitalization
253.84B

MRK Merck & Co Forecast, Technical & Fundamental Analysis

Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections... Show more

MRK
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for MRK with price predictions
Nov 28, 2025

MRK's RSI Oscillator sits in overbought zone for 12 days

The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 12 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where MRK declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

MRK broke above its upper Bollinger Band on November 25, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for MRK entered a downward trend on November 10, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on November 11, 2025. You may want to consider a long position or call options on MRK as a result. In of 78 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for MRK just turned positive on November 11, 2025. Looking at past instances where MRK's MACD turned positive, the stock continued to rise in of 48 cases over the following month. The odds of a continued upward trend are .

MRK moved above its 50-day moving average on November 05, 2025 date and that indicates a change from a downward trend to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where MRK advanced for three days, in of 332 cases, the price rose further within the following month. The odds of a continued upward trend are .

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating outstanding price growth. MRK’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.895) is normal, around the industry mean (8.915). P/E Ratio (13.528) is within average values for comparable stocks, (23.825). Projected Growth (PEG Ratio) (1.077) is also within normal values, averaging (2.041). Dividend Yield (0.032) settles around the average of (0.026) among similar stocks. P/S Ratio (4.011) is also within normal values, averaging (3.624).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 73, placing this stock slightly better than average.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

View a ticker or compare two or three
MRK
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

MRK is expected to report earnings to fall 20.54% to $2.05 per share on February 03

Merck & Co MRK Stock Earnings Reports
Q4'25
Est.
$2.05
Q3'25
Beat
by $0.23
Q2'25
Beat
by $0.10
Q1'25
Beat
by $0.08
Q4'24
Missed
by $0.09
The last earnings report on October 30 showed earnings per share of $2.58, beating the estimate of $2.35. With 12.54M shares outstanding, the current market capitalization sits at 253.84B.
A.I.Advisor
published Dividends

MRK paid dividends on October 07, 2025

Merck & Co MRK Stock Dividends
А dividend of $0.81 per share was paid with a record date of October 07, 2025, and an ex-dividend date of September 15, 2025. Read more...
A.I. Advisor
published General Information

General Information

a developer of human and animal health products

Industry PharmaceuticalsMajor

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
126 East Lincoln Avenue
Phone
+1 908 740-4000
Employees
72000
Web
https://www.merck.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
TUG40.770.39
+0.97%
STF Tactical Growth ETF
PLDR37.470.06
+0.17%
Putnam Sustainable Leaders ETF
SCHX26.910.04
+0.15%
Schwab US Large-Cap ETF™
APMU25.09-0.01
-0.05%
ActivePassive Intermediate Mcpl Bd ETF
XYZG13.62-2.09
-13.33%
Leverage Shares 2X Long XYZ Daily ETF

MRK and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, MRK has been closely correlated with PFE. These tickers have moved in lockstep 68% of the time. This A.I.-generated data suggests there is a high statistical probability that if MRK jumps, then PFE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MRK
1D Price
Change %
MRK100%
-0.76%
PFE - MRK
68%
Closely correlated
-0.46%
BMY - MRK
58%
Loosely correlated
-1.88%
ABBV - MRK
58%
Loosely correlated
-0.32%
AZN - MRK
56%
Loosely correlated
-0.37%
BIIB - MRK
55%
Loosely correlated
+1.51%
More

Groups containing MRK

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MRK
1D Price
Change %
MRK100%
-0.76%
MRK
(2 stocks)
99%
Closely correlated
+1.55%